For Clinical Genetics Labs

Offer your customers the latest PRS for clinical grade risk prediction. Upload your SNP array or NGS data and our software performs PRS analysis in a cloud architecture that is fully automated, GDPR-HIPAA compliant and certified as a Medical Device. Differentiate your clinic from the crowd, embrace data-driven healthcare and generate a new source of revenue.

For Researchers

You’re just two clicks away from your next PRS paper. Use our platform to perform the entire PRS pipeline, QC and imputation, without writing a single line of code. Run and compare the performance of the most cited PRS methods, such as LD-Pred and Clumping and Thresholding. Focus only on what really matters for your research project without the hassle of informatics.

For Pharmas

Stratify participants of your clinical trials according to their genomic diversity. Use our software to identify individuals at with different underlying risk so that you can target your trial population saving your company money and time while having a better trial outcome. A simple genotyping array unlocks precious information on your cohort, invaluable to follow up decision-making in the modern area of drug development.

Trusted Translational Genomics

Allelica has built the first cloud platform that allows you to perform Polygenic Risk Score (PRS) analysis without writing a single line of code. The cloud architecture is a secure and trusted environment that has been certified as a Medical Device and is GDPR and HIPAA complaint. We work with leading clinical genetics labs, pharmaceutical companies and research institutes to improve health care prevention for a large number of complex diseases. The cloud platform accepts as input genotyping array and NGS data, performs genomic prediction analysis with published PRS or with your newly developed PRS.

Validation and testing on the UKBiobank is performed with just two clicks.

Why you should choose Allelica
scientist

Made by scientists

Allelica software and algorithms have been developed thanks to a collaboration between researchers who have trained at Oxford University and the University of Rome “La Sapienza”.

software
Software as a Service
Use our SaaS for easy and fast data analysis and report. Use our pipelines to safely scale your genomic anaysis.
privacy
Privacy and Security
We give absolute priority to the privacy of your data. The genetic data are encoded through a secure protocol and encrypted in a single tenant node.

Appeared on

repubblica
rai1
fortune
Home_Page_31

The Latest from Genomicriskscore

esc

At the “ESC 2019 together with World Congress of Cardiology”, held in Paris in the first week of September, Allelica presented the newly developed software to compute Polygenic Risk Score (PRS) for Coronary Artery Disease. The clinical value of integrating PRS in traditional risk models was also discussed.

genomicslive

Come to meet us in Basel, Switzerland, at the GenomicsLive Conference. The Europe’s leading conference designed to deliver diagnostics and digital technologies into the clinic. The event will cover diagnostics, digital pathology and clinical aspects of precision medicine. See you at our booth on the 4th and the 5th of December.

What we do

Home_Page_37

Perform Risk Prediction Analysis

Use the Allelica in Cloud software to perform Polygenic Risk Score Analysis in a fast and safe way.

Home_Page_40

Preventive Healthcare

Provide the latest clinical grade Polygenic Risk Score for complex diseases published on high impact factor journals.

Home_Page_44
Cumulative  risk of Breast Cancer (BC) in UK Biobank female stratified by different percentiles of the Polygenic Risk Score (PRS)
Home_Page_46
Prevalence gradient for Breast Cancer (BC) across the distribution of the Polygenic Risk Score in UK Biobank population. Each point represents a different percentile of the PRS distribution.
Home_Page_50
Cumulative risk of Coronary Artery Disease (CAD) in UK Biobank population by different percentiles of the Polygenic Risk Score (PRS).
Home_Page_51
Prevalence gradient for Coronary Artery Disease (CAD) across the distribution of the Polygenic Risk Score in UK Biobank population. Each point represents a different percentile of the PRS distribution.
Home_Page_54
Bar chart showing the association between Polygenic Risk Scores (PRS) quintiles (third and fifth), Body Mass Index (BMI), and the risk of developing Type 2 Diabetes (T2D).
Home_Page_56
Prevalence gradient for Type 2 Diabetes (T2D) across the distribution of the Polygenic Risk Score in UK Biobank population. Each point represents a different percentile of the PRS distribution.

Allelica founders carried out research at the University of

oxford
Home_Page_63

Funded by

The European project for innovation in Health

Home_Page_73

The Seed Fund

Home_Page_75

The Italian Pree-Seed grant to support Research Spin-Off

Home_Page_77